EKSO logo

Ekso Bionics Holdings (EKSO)

Profile

Full Name

Ekso Bionics Holdings, Inc.

Ticker Symbol

EKSO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 17, 2014

Indexes

Not included

Website

http://www.eksobionics.com

Employees

61

Key Details

Price

$0.38(+3.56%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$17.93M(-1.94% YoY)

Annual EPS

-$0.56(+49.09% YoY)

PE ratio

-

Next earnings date

Apr 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.38
EKSO price is $0.38

30-Day Relative Volume

0.42
EKSO 30-day relative volume is 0.42

Price Performance

Price Most recent change

+3.56%
EKSO price was up +3.56% on Apr 14, 2025

Price YTD change

-38.03%
EKSO price is down -38.03% since January 1st

Price 1-year change

-73%
EKSO price is down -73% year-on-year

Price 3-year change

-86%
EKSO price is down -86% over the past 3 years

Price Range

Price All-time high

$863.10
EKSO price is currently -99.96% below its historical high of $863.10

Price 3-year low

$0.34
EKSO price is currently +9.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.38M
EKSO market capitalization is $9.38 million

Market cap 3-year change

-72.94%
EKSO market capitalization is down -72.94% over the past 3 years

Market cap All-time high

$777.63M
EKSO market capitalization is currently -98.79% below its historical high of $777.63 million

Market cap sector rank

19.06%
EKSO market capitalization is higher than 19.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+37.16%
EKSO shares outstanding is up +37.16% year-on-year

Shares Outstanding 3-Year Change

+93.27%
EKSO shares outstanding is up +93.27% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
EKSO beta is 0.76

200-day SMA

$0.82
EKSO price is currently -53.89% below its 200-day simple moving average

50-day SMA

$0.47
EKSO price is currently -19.45% below its 50-day simple moving average

RSI

38.98
EKSO 14-day relative strength index is 38.98

Volume

0.42
EKSO 30-day relative volume is 0.42

ATR

$0.04
EKSO average true range is $0.04

10-day Historical Volatility

78.41%
EKSO 10-day historical volatility is 78.41%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$17.93M
EKSO annual revenue is $17.93 million

Revenue Analysts estimate

$22.00M
EKSO annual revenue is currently -18.51% lower than the consensus analysts' forecast

Revenue 1-year change

-1.94%
EKSO annual revenue is down -1.94% year-on-year

Revenue Sector rank

33.03%
EKSO annual revenue is higher than 33.03% of companies in Healthcare sector

EPS

EPS

-$0.56
EKSO annual earnings per share is -$0.56

EPS Analysts estimate

-
EKSO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+49.09%
EKSO annual earnings per share is up +49.09% year-on-year

EPS Sector rank

66.91%
EKSO annual earnings per share is higher than 66.91% of companies in Healthcare sector

Profit

Gross profit

$9.51M
EKSO annual gross profit is $9.51 million

Gross margin

53.06%
EKSO annual gross profit margin is 53.06%

Operating profit

-$10.46M
EKSO annual operating income is -$10.46 million

Operating margin

-58.35%
EKSO annual operating profit margin is -58.35%

Net income

-$11.33M
EKSO annual net profit is -$11.33 million

Net margin

-63.21%
EKSO annual net profit margin is -63.21%

Expenses

Total expenses

$28.39M
EKSO annual total expenses is $28.39 million

Operating expenses

$19.97M
EKSO annual total operating expenses is $19.97 million

Cost of goods sold

$8.41M
EKSO annual cost of goods sold is $8.41 million

Selling, general & administrative expenses

$16.10M
EKSO annual SGA is $16.10 million

Depreciation and amortization

$1.61M
EKSO annual depreciation & amortization is $1.61 million

Interest expense

$269.00K
EKSO annual interest expense is $269.00 thousand

Income tax

-
EKSO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$11.06M
EKSO annual earnings before interest & taxes is -$11.06 million

EBITDA

-$9.45M
EKSO annual EBITDA is -$9.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$26.65M
EKSO annual total assets is $26.65 million

Non current assets

$7.81M
EKSO annual long term assets is $7.81 million

Current assets

$18.84M
EKSO annual total current assets is $18.84 million

Cash and cash equivalents

$6.49M
EKSO annual cash & cash equivalents is $6.49 million

Accounts receivable

$7.24M
EKSO annual accounts receivable is $7.24 million

Inventory

$4.57M
EKSO annual inventory is $4.57 million

Liabilities

Total liabilities

$13.95M
EKSO annual total liabilities is $13.95 million

Long term liabilities

$6.41M
EKSO annual total long term liabilities is $6.41 million

Current liabilities

$7.54M
EKSO annual total current liabilities is $7.54 million

Accounts payable

$1.55M
EKSO annual accounts payable is $1.55 million

Debt

Total debt

$5.98M
EKSO annual total debt is $5.98 million

Total debt 1-year change

-16.53%
EKSO annual total debt is down -16.53% year-on-year

Long term debt

$4.31M
EKSO annual long term debt is $4.31 million

Short term debt

$1.68M
EKSO annual short term debt is $1.68 million

Equity & Capital

Shareholders equity

$12.71M
EKSO annual stockholders equity is $12.71 million

Book value

$12.71M
EKSO annual book value is $12.71 million

Retained earnings

-$250.47M
EKSO annual retained earnings is -$250.47 million

Working capital

$11.31M
EKSO annual working capital is $11.31 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.85M
EKSO annual cash flow from operations is -$9.85 million

Cash from operations 1-year change

+18.32%
EKSO annual cash flow from operations is up +18.32% year-on-year

Cash from investing

-$37.00K
EKSO annual cash flow from investing activities is -$37.00 thousand

Cash from investing 1-year change

+76.43%
EKSO annual cash flow from investing activities is up +76.43% year-on-year

Cash from financing

$7.77M
EKSO annual cash flow from financing activities is $7.77 million

Cash from financing 1-year change

+2132.47%
EKSO annual cash flow from financing activities is up +2132.47% year-on-year

CAPEX

CAPEX

$37.00K
EKSO annual capital expenditures is $37.00 thousand

CAPEX 1-year change

-76.43%
EKSO annual capital expenditures is down -76.43% year-on-year

Free Cash Flow

Free cash flow

-$9.88M
EKSO annual free cash flow is -$9.88 million

Free cash flow 1-year change

+19.06%
EKSO annual free cash flow is up +19.06% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

53.06%
EKSO annual gross profit margin is 53.06%

Operating margin

-58.35%
EKSO annual operating profit margin is -58.35%

Net margin

-63.21%
EKSO annual net profit margin is -63.21%

ROA & ROE

ROA

-40.78%
EKSO annual return on assets is -40.78%

ROE

-89.52%
EKSO annual return on equity is -89.52%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EKSO price to earnings ratio value is unknown

PE ratio Sector rank

-
EKSO price to earnings ratio is unknown

PB Ratio

PB ratio

0.74
EKSO price to book ratio is 0.74

PB ratio Sector rank

37.75%
EKSO price to book ratio is higher than 37.75% of companies in Healthcare sector

PS Ratio

PS ratio

0.52
EKSO price to sales ratio is 0.52

PS ratio Sector rank

17.05%
EKSO price to sales ratio is higher than 17.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.87M
EKSO enterprise value is $8.87 million

Enterprise value Sector rank

23.78%
EKSO enterprise value is higher than 23.78% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.94
EKSO EV/EBITDA is -0.94

EV/EBITDA Sector rank

43.79%
EKSO EV/EBITDA is higher than 43.79% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.50
EKSO annual current ratio is 2.50

Quick ratio

1.89
EKSO annual quick ratio is 1.89

Leverage

Debt to equity

0.40
EKSO annual debt to equity ratio is 0.40

Interest coverage ratio

-41.12
EKSO annual interest coverage ratio is -41.12

Risk & Stability

Piotroski F-Score

5
EKSO piotroski f-score is 5

Altman Z-Score

-12.94
EKSO altman z-score is -12.94

Analyst ratings

Recent major analysts updates

Mar 4, 25 Lake Street
Buy
Mar 4, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Oct 29, 24 Lake Street
Buy
Oct 29, 24 HC Wainwright & Co.
Buy
Jul 30, 24 HC Wainwright & Co.
Buy
Jun 24, 24 Lake Street
Buy
Apr 30, 24 HC Wainwright & Co.
Buy
Mar 5, 24 HC Wainwright & Co.
Buy
Jan 22, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

MGRX logo
Mangoceuticals (MGRX)
HCWB logo
HCW Biologics (HCWB)
NeurAxis (NRXS)
HOOK logo
HOOKIPA Pharma (HOOK)
BCDA logo
BioCardia (BCDA)
HCTI logo
Healthcare Triangle (HCTI)
SNSE logo
Sensei Biotherapeutics (SNSE)
COSCIENS Biopharma (CSCI)
XTLB logo
XTL Biopharmaceuticals (XTLB)
  • What is the ticker symbol for Ekso Bionics Holdings?
  • Does Ekso Bionics Holdings pay dividends?
  • What sector is Ekso Bionics Holdings in?
  • What industry is Ekso Bionics Holdings in?
  • What country is Ekso Bionics Holdings based in?
  • When did Ekso Bionics Holdings go public?
  • Is Ekso Bionics Holdings in the S&P 500?
  • Is Ekso Bionics Holdings in the NASDAQ 100?
  • Is Ekso Bionics Holdings in the Dow Jones?
  • When was Ekso Bionics Holdings's last earnings report?
  • When does Ekso Bionics Holdings report earnings?
  • Should I buy Ekso Bionics Holdings stock now?

What is the ticker symbol for Ekso Bionics Holdings?

The ticker symbol for Ekso Bionics Holdings is NASDAQ:EKSO

Does Ekso Bionics Holdings pay dividends?

No, Ekso Bionics Holdings does not pay dividends

What sector is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Healthcare sector

What industry is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Medical Instruments & Supplies industry

What country is Ekso Bionics Holdings based in?

Ekso Bionics Holdings is headquartered in United States

When did Ekso Bionics Holdings go public?

Ekso Bionics Holdings's initial public offering (IPO) was on January 17, 2014

Is Ekso Bionics Holdings in the S&P 500?

No, Ekso Bionics Holdings is not included in the S&P 500 index

Is Ekso Bionics Holdings in the NASDAQ 100?

No, Ekso Bionics Holdings is not included in the NASDAQ 100 index

Is Ekso Bionics Holdings in the Dow Jones?

No, Ekso Bionics Holdings is not included in the Dow Jones index

When was Ekso Bionics Holdings's last earnings report?

Ekso Bionics Holdings's most recent earnings report was on Mar 3, 2025

When does Ekso Bionics Holdings report earnings?

The next expected earnings date for Ekso Bionics Holdings is Apr 29, 2025

Should I buy Ekso Bionics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page